Artificial Lung Market Overview
The global Artificial Lung Market was valued at USD 3.18 billion in 2025 and is projected to reach USD 7.39 billion by 2032, expanding at a CAGR of 12.78% during the forecast period. The market is experiencing substantial growth due to the increasing prevalence of chronic respiratory diseases, advancements in extracorporeal life-support technologies, and growing demand for innovative solutions that can temporarily or permanently support lung function.

An artificial lung is a medical device designed to perform the critical functions of the human lungs by oxygenating blood and removing carbon dioxide. These systems are widely used in patients suffering from severe respiratory failure, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and during lung transplantation procedures. Artificial lungs play a crucial role in modern critical care and cardiothoracic surgery, particularly when conventional ventilation methods are insufficient.

♦ Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/88705/

Research Methodology and Market Scope
The Artificial Lung Market report provides a comprehensive assessment of industry trends, technological advancements, competitive developments, and regional opportunities. The study evaluates market performance using primary and secondary research methodologies, including interviews with healthcare professionals, device manufacturers, researchers, and industry stakeholders. Market estimates are based on revenue analysis, technological adoption patterns, regulatory developments, and healthcare infrastructure expansion across key regions.

The report covers market segmentation by product, technology, application, and end-user while analyzing regional growth patterns and strategic initiatives undertaken by major market participants.

Artificial Lung Market Dynamics
Rising Prevalence of Respiratory Disorders Driving Market Growth
One of the major factors fueling market expansion is the increasing incidence of respiratory diseases worldwide. Chronic Obstructive Pulmonary Disease (COPD) remains one of the leading causes of mortality globally, with millions of patients requiring advanced respiratory support solutions. Growing tobacco consumption, environmental pollution, occupational hazards, and aging populations continue to contribute to the rising burden of respiratory illnesses.

Additionally, the demand for lung transplantation is increasing steadily. However, the shortage of donor organs has intensified the need for artificial lung technologies capable of serving as bridge-to-transplant or destination therapies. As healthcare systems seek alternatives to address donor shortages, artificial lungs are emerging as a promising solution.

Continuous Technological Advancements Accelerating Adoption
Ongoing research and development activities are transforming the artificial lung landscape. Manufacturers and research institutions are focused on improving gas exchange efficiency, reducing complications, enhancing biocompatibility, and developing portable systems that improve patient mobility.

Recent industry developments highlight the momentum within the sector. In 2026, Abbott Laboratories secured FDA approval for its next-generation CardioMEMS HERO device, enhancing respiratory and cardiac patient monitoring capabilities. LivaNova reported strong growth in cardiopulmonary revenues driven by increasing adoption of advanced perfusion systems. Meanwhile, companies such as VQ Biomedical and Getinge continue investing in innovative respiratory support technologies aimed at improving patient outcomes and expanding treatment options.

The introduction of PFAS-free medical-grade materials by Saint-Gobain Tape Solutions further supports the development of safer and more sustainable artificial lung components, aligning with evolving regulatory requirements.

Artificial Lung Market Segment Analysis
By Product
The Membrane Artificial Lung segment dominated the market in 2025 and accounted for the largest revenue share. These devices offer superior gas exchange performance, improved biocompatibility, and lower risks of blood damage compared to traditional technologies. Their widespread application in Extracorporeal Membrane Oxygenation (ECMO) procedures and cardiothoracic surgeries has significantly contributed to market leadership.

In contrast, Bubble Artificial Lung systems are experiencing declining adoption due to safety concerns and the availability of more advanced membrane-based alternatives. Despite their historical significance and lower cost, technological advancements have shifted market preference toward membrane oxygenators.

By Technology
Among technology segments, Extracorporeal Membrane Oxygenation (ECMO) remains the dominant category. ECMO systems are increasingly utilized in intensive care units to support patients suffering from severe respiratory and cardiac failure.

Pump-driven artificial lungs continue to gain traction due to their ability to provide controlled circulation and oxygenation. Meanwhile, Pumpless Artificial Lung Systems, including Interventional Lung Assist (iLA), are attracting interest for specific clinical applications requiring reduced mechanical complexity and enhanced patient comfort.

By Application
The market serves a broad range of clinical applications, including:

Acute Respiratory Distress Syndrome (ARDS)
Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Hypertension
Lung Transplantation
Cardiothoracic Surgery
Other Respiratory Disorders
ARDS and COPD account for significant market demand due to their increasing prevalence and the need for advanced respiratory support technologies in critical care settings.

♦ Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/88705/

By End-User
Hospitals represented the largest end-user segment in 2025. The presence of specialized intensive care units, advanced infrastructure, and skilled healthcare professionals has made hospitals the primary setting for artificial lung deployment.

Emergency Centers are witnessing notable growth owing to the increasing number of respiratory emergencies and trauma-related complications. Specialty clinics, ambulatory surgical centers, and research institutes are also contributing to market expansion through specialized treatment services and clinical research initiatives.

Regional Insights
Asia Pacific Leads Global Market Growth
Asia Pacific emerged as the largest regional market in 2025 and is expected to maintain its dominance throughout the forecast period. Countries such as China, Japan, and India are investing heavily in healthcare modernization, critical care infrastructure, and advanced life-support technologies. The large patient population and increasing awareness of ECMO therapies further strengthen regional growth prospects.

North America Maintains Strong Market Position
North America holds a significant share of the global market due to advanced healthcare infrastructure, favorable reimbursement policies, strong research capabilities, and widespread adoption of innovative respiratory support technologies. The region also benefits from the presence of leading manufacturers and extensive clinical research activities.

Europe Shows Steady Expansion
Europe continues to witness stable market growth supported by well-established healthcare systems, increasing cardiothoracic surgical procedures, and ongoing investments in advanced medical technologies.

Emerging Opportunities in South America and Middle East & Africa
Healthcare infrastructure improvements and increasing investments in critical care services are creating new opportunities across South America and the Middle East & Africa. Although these regions currently represent a smaller market share, gradual adoption of advanced life-support systems is expected to drive future growth.

♦ Download a free sample of the unmanned composites market report:https://www.maximizemarketresearch.com/market-report/artificial-lung-market/88705/

Competitive Landscape
The Artificial Lung Market remains highly competitive, with leading companies focusing on innovation, strategic partnerships, product development, and regulatory approvals to strengthen their market positions.

Key companies operating in the market include:

ALung Technologies
Breethe
Haemair
Lung Biotechnology PBC
McGowan Institute for Regenerative Medicine
MedArray
Miromatrix Medical
Xenios
Medtronic
Getinge
LivaNova
Terumo Corporation
MicroPort Scientific Corporation
Nipro Corporation
Fresenius Medical Care
Abiomed
Abbott Laboratories
Asahi Kasei Medical
Braile Biomedica
Oxyplus Technologies
Hemovent
Inspira Technologies
Conclusion
The Artificial Lung Market is poised for significant growth through 2032, driven by the increasing prevalence of respiratory diseases, growing demand for ECMO and advanced life-support technologies, and continuous innovation in artificial organ development. As healthcare providers seek effective solutions for managing severe respiratory conditions and addressing donor organ shortages, artificial lung technologies are expected to play an increasingly important role in the future of critical care medicine. Continued investments in research, technological advancements, and expanding healthcare infrastructure will further accelerate market adoption worldwide.



◉ Get Market Research Latest Trends

Route Optimization Software Market

Plastic Films and Sheets Market

Global Consent Management Market

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India
[email protected]
+91 96071 95908, +91 9607365656